Comparing different adjuvants for vaccines against flu and certain infections
ADJUVANT COMPARISON AND CHARACTERIZATION
This study is looking at how different ingredients in vaccines can make them work better against the flu and certain infections, with the goal of creating vaccines that offer stronger protection for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11122156 on NIH RePORTER |
What this research studies
This research investigates how various adjuvants enhance the effectiveness of vaccines against influenza and infections caused by Chlamydia muridarum and Coxiella burnetii. By comparing these adjuvants side-by-side, the study aims to create detailed immunological profiles, known as 'immune fingerprints', that reveal how different adjuvants work in the body. This information could help in developing more effective vaccines tailored to specific immune responses. Patients may benefit from improved vaccine formulations that provide better protection against these diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for influenza and infections caused by Chlamydia muridarum and Coxiella burnetii.
Not a fit: Patients who are not at risk for these infections or who have already been vaccinated may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that enhance immune responses against influenza and certain bacterial infections.
How similar studies have performed: Previous research has shown promise in using adjuvants to enhance vaccine efficacy, indicating that this approach has potential for success.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Felgner, Philip — University of California-Irvine
- Study coordinator: Felgner, Philip
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.